<DOC>
	<DOCNO>NCT00765336</DOCNO>
	<brief_summary>Researchers want find Minocycline Extended-Release Tablets affect sperm-production healthy male . The study include Minocycline Extended-Release Tablets , new once-daily formulation minocycline , compare placebo inactive pill . Approximately 170 healthy adult male assign chance ( like flip coin ) 2 treatment group approximately 85 subject per group . You treat either Minocycline Extended-Release Tablets placebo daily . Screening occur within 14 day prior first dose study drug . Required study activity include : - Written inform consent - Weight - Two semen collection within 48-72 hour one another screen visit Days 84,112 , 140 , 168 - Blood draw screen visit Days 84 , 112 , 140 , 168 - Genital examination ( exclude prostate ) screen Day 84 Day 112 visit - Medical history You continue treatment phase study 12 week . You return clinic 4 week 8 week completion treatment phase study , final study visit approximately 12 week last dose . Participation 24-weeks . Up 10 investigational site enroll subject study .</brief_summary>
	<brief_title>A Study Examine Effects Minocycline Extended-Release Tablets Sperm Production Human Males .</brief_title>
	<detailed_description />
	<mesh_term>Minocycline</mesh_term>
	<criteria>Males least 18 year age Weight 45 kg 136.36 kg ( 99300 lb ) Must understand give consent voluntarily study comply study requirement Subjects must ejaculate 48 72 hour prior collection first specimen ( PreCollection Ejaculation ) refrain ejaculation Specimen 1 collect . The second ejaculation sample Specimen 2 ) must collect 48 hour 72 hour Specimen 1 . No ejaculation permit Specimen 1 Specimen 2 Must refrain use saunas hot tub duration study 168 day ) Must non smoker Must medically healthy determine investigator physician ( via medical history clinical laboratory test ) Must sperm parameter ( average Specimen 1 Specimen 2 ) within clinically acceptable limit screen define : Total sperm concentration ≥20 x 106/mL10 % motile ≥50 % 10 % normal morphology &gt; 4.4 % 14 Known allergy/sensitivity minocycline drug product component Use antacid dietary supplement contain aluminum , calcium , iron , magnesium History vestibular incident include vertigo , lightheadedness , nausea , vomit within 30 day prior enrollment Known history alcohol drug dependency , significant within past 2 year Known history current risk hepatic dysfunction Known history current risk renal dysfunction , e.g. , uncontrolled diabetes Systemic lupus erythematosis ( SLE ) positive ANA screen Receipt experimental drug within 120 day prior Study Day 0 NonLFT clinical laboratory value outside normal range determine clinical significance Liver function test great 1.5 time upper limit normal ( ALT , AST , GGT ) Use tetracycline , erythromycin within 12 week Day 0</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Spermatogenesis Healthy Males</keyword>
</DOC>